首页>
外国专利>
Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C
Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C
展开▼
机译:血浆葡萄糖神经酰胺缺乏是血栓形成的危险因素和抗凝蛋白C的调节剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention has determined that exogenously added glycosylceramide (GlcCer) and other neutral glycolipids such as the homologous Glc-containing globotriaosylceramide (Gb3Cer), dose-dependently prolonged clotting times of normal plasma in the presence but not absence of APC:protein S, indicating GlcCer or Gb3Cer can enhance protein C pathway anticoagulant activity. In studies using purified proteins, inactivation of factor Va by APC:protein S was enhanced by GlcCer alone and by GlcCer, globotriaosylceramide, lactosylceramide, and galactosylceramide in multicomponent vesicles containing phosphatidylserine and phosphatidylcholine. Thus, the present invention provides neutral glycolipids such as GlcCer and Gb3Cer, as anticoagulant cofactors that contribute to the antithrombotic activity of the protein C pathway. The present invention has also determined that a deficiency of plasma GlcCer is a risk factor for thrombosis. Methods are provided to determine individuals at risk for thrombosis, methods of treatment as well as methods of screening for antithrombotic factors from neutral glycolipids.
展开▼